The trajectory of individual ADC targets in lung cancer is reviewed, the latest clinical trial results are described, and future innovations in ADC therapies and potential mechanisms of resistance are discussed.
Henry Pickett, J. Arias-Romero, Jeremy Fricke et al.· Trends in Cancer· 0 citations
Oral cavity squamous cell carcinoma (OCSCC) is a common epithelial malignancy for which site-specific biomarkers with proven prognostic utility remain limited. In this study, we present one of the largest single-center, site-specific molecular analyses of OCSCC to date. Using two separate versions of multigene next-gen...
M. Afkhami, N. Haghighi, H. Ma et al.· Head and Neck Pathology· 0 citations
Current AI applications in lung cancer related to radiologic imaging, digital pathology, genomics, immunohistochemistry, and Cell Painting morphology are examined and their potential to be incorporated into a proposed multimodal model is examined.
T. Chakrabarti, A. Mansour, Xi-Wei Wu et al.· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.